BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, announced that it has entered into a Commitment Letter with certain funds managed by Highbridge Capital Management, LLC (“Highbridge”), pursuant to which Highbridge has committed to provide a … [Read more…]
BOSTON–(BUSINESS WIRE)–Gamida Cell Ltd. (Nasdaq: GMDA), the global leader in the development of NAM-enabled cell therapies for patients with hematologic and solid cancers and other serious diseases, today announced the pricing of a follow-on public offering of 12,905,000 of its ordinary shares at a public offering price of $1.55 per share for aggregate gross proceeds … [Read more…]
BEIJING–(BUSINESS WIRE)–#ADC–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) will host a seminar at the BioJapan2022 Conference on Friday, October 14. The seminar, consisting of 3 modules, will introduce: Five RenMiceTM-based fully human antibody discovery platforms: RenMabTM-based monoclonal antibody platform, RenLite®-based bispecific antibody and bispecific ADC platforms, TCR-mimic platform, and GPCR platform Progress of Project … [Read more…]
Work begins on modern inpatient behavioral health treatment and education facility in Metro Detroit, slated to open in 2024 WEST BLOOMFIELD, Mich.–(BUSINESS WIRE)–Henry Ford Health, one of the nation’s premier academic and integrated health systems, and Acadia Healthcare, the nation’s largest stand-alone behavioral healthcare company, broke ground today on a state-of-the-art behavioral health treatment and … [Read more…]
Approval also marks the second NGS-based companion diagnostic to identify RET-fusion positive locally advanced or metastatic non-small cell lung cancer (NSCLC) CARLSBAD, Calif.–(BUSINESS WIRE)–The U.S. Food and Drug Administration (FDA) has granted approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to aid in selection of patients with RET-fusion positive … [Read more…]
Career healthcare finance executive brings extensive experience to Kyros, a first of its kind digital platform for recovery services, as first C-suite hire. MINNEAPOLIS–(BUSINESS WIRE)–Kyros, the nation’s first of its kind digital platform for people and organizations within the recovery community, has added Nick Christianson as Chief Financial Officer. Nick is the first C-Suite hire … [Read more…]
ROCKVILLE, Md.–(BUSINESS WIRE)–BIOQUAL’s Board of Directors has declared a dividend of $1.00 per share for shareholders of record on October 6, 2022, payable on October 27, 2022. This is the twenty-first dividend declared by BIOQUAL. Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements … [Read more…]
Supported by TELUS Health, LifeWorks’ Mental Health Index™ finds negative workplace culture impacts mental health and leads to two and a half times less productivity than positive environments CHICAGO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions supported by TELUS Health, today released its monthly Mental Health Index™ revealing that four out … [Read more…]
Award recognizes Dr. Jones’ exceptional leadership in community contributions PHOENIX–(BUSINESS WIRE)–University of Phoenix celebrates that College of Nursing faculty Sun Jones, DNP, RN, FNP-BC, who serves as the Systematic Plan for Evaluation and Curriculum leader, is the recipient of the 2022 March of Dimes Arizona HEROES IN ACTION Leadership Award. The March of Dimes Arizona … [Read more…]
IRVINE, Calif.–(BUSINESS WIRE)–#CSA–Immunis, Inc., a private biotech company generating an innovative treatment for age and disease-related immune decline, announces that its Chairman, Dr. Hans Keirstead, delivered a keynote on behalf of the National Institute of Child Sexual Assault (NICSA) at the UN General Assembly in New York City. As part of Immunis’ ongoing Corporate Social … [Read more…]
